|
ER-/PgR+ breast cancer is a separate entity characterized by distinct phenotype: Comprehensive reevaluation of cases from Polish and Hungarian centers. |
|
|
Honoraria - Amgen; AstraZeneca; Egis Pharmaceuticals; Genomic Health; Lilly; Novartis; Pfizer; Pierre Fabre |
Consulting or Advisory Role - Amgen; AstraZeneca; Clinigen Group; Egis Pharmaceuticals; Genomic Health; Lilly; Novartis; Pfizer; Roche; Sandoz; TLC Biopharmaceuticals |
Speakers' Bureau - Amgen; AstraZeneca; Egis Pharmaceuticals; Genomic Health; Novartis; Pfizer; Pierre Fabre; Roche |
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Egis Pharmaceuticals; Novartis; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Travel, Accommodations, Expenses - Roche |
|
|
Honoraria - Amgen; Clovis Oncology; Incyte; Novartis; Odonate Therapeutics; Pfizer; Regeneron; Roche; Tesaro |
Travel, Accommodations, Expenses - Roche |
|
|
Honoraria - Amgen; Pfizer; Roche |
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer |
Travel, Accommodations, Expenses - Pfizer; SERVIER; Teva |
|
|
Honoraria - Alvogen; Amgen; AstraZeneca; Egis Pharmaceuticals; Novartis; Pfizer; Pierre Fabre; Roche; Teva |
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche |
Speakers' Bureau - Novartis; Roche |
Research Funding - AstraZeneca; Lilly; Merck; Novartis; Pfizer; Roche |
Travel, Accommodations, Expenses - Amgen; Pfizer; Pierre Fabre; Roche |
|
|
Consulting or Advisory Role - Genomic Health; Novartis |
Travel, Accommodations, Expenses - Roche |
|
|
No Relationships to Disclose |
|
|
Honoraria - Accord Healthcare; BioStat Solutions; Brass Research and Development; Egis Pharmaceuticals; ETET; MSD; Novartis; Teva |
Consulting or Advisory Role - ETET |
Speakers' Bureau - Accord Healthcare; Egis Pharmaceuticals; MSD; Novartis |
Research Funding - Amgen; BioStat Solutions; Brass Research and Development; Merck; MSD |
Travel, Accommodations, Expenses - Accord Healthcare |
|
|
No Relationships to Disclose |